Navigation Links
Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium (E5564) To Be Well Tolerated in Patients with Severe Sepsis
Date:12/22/2009

x days) and 94 patients received eritoran high-dose (105mg given every 12 hours for six days). Seven patients did not receive any trial drug and were not included in the modified intent to treat population for analysis. Eritoran or placebo doses were administered via intravenous infusion within 12 hours of recognition of severe sepsis and repeated every 12 hours for six days.

In this Phase II trial, eritoran was well tolerated, and the following adverse events were found:

Anemia, diarrhea, insomnia, acute renal failure and rash were observed more frequently in the group receiving eritoran compared to the group receiving placebo, although not statistically significant.

Serious adverse events that occurred in greater than 5% of patients in both the eritoran and placebo treated groups included cardiac arrest, multiorgan failure, sepsis, respiratory failure and deep vein thrombosis.

Four patients in the group receiving eritoran experienced a hepatobiliary serious adverse event compared with none in the group receiving placebo. Three of these four subjects had pre-existing liver disease.

A higher incidence of atrial fibrillation seen in the eritoran high-dose group (12.8%) compared to placebo (7.3%) was not statistically significant. Instances were mild or moderate in severity and it was unclear if the increased incidence is related to eritoran administration.

Phlebitis (inflammation of the vein) was observed in 6.7% of patients dosed with eritoran high-dose through a peripheral vein (versus 1.6% through central line); affected subjects recovered. No patient in the group receiving placebo experienced phlebitis.

The occurrence of infectious complications reported as adverse events by trial investigators did not differ notably among the three groups.

The mortality in the placebo, low-dose and high-dose groups was 33.3%, 32% and 26.6% respectively. Although not statistically signific
'/>"/>

SOURCE Eisai
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
3. American Imaging Managements New Specialty Drug Program Delivers Immediate Results
4. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
5. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
6. Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010
7. Robbins & Myers To Release First Quarter Fiscal 2010 Financial Results
8. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
9. AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial
10. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
11. Neogen Corporation Announces 2nd Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... SAN DIEGO , 29 septembre ... désignée Daiichi Sankyo) (TSE : 4568) et Ambit Biosciences ... d,un accord de fusion définitif en vertu duquel ... actions ordinaires en circulation d,Ambit Biosciences à 15 ... d,une offre publique d,achat qui sera suivie d,une ...
(Date:9/29/2014)... 2014  BioMed Realty Trust, Inc. (NYSE: ... lease for approximately 200,000 square feet for 12 years ... Inc., at 650 East Kendall Street in ... Realty through a joint venture with Prudential Real Estate ... and research and development (R&D) center at the site ...
(Date:9/29/2014)... Sept. 29, 2014  Moberg ( www.moberg.com ) ... Monitor, a medical device used for advanced monitoring ... certifies that a product has met European Union ... . The CNS Monitor captures ... or brain waves) to support neurological patient care. ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts 2BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts 3Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2
... June 9, 2011 Reportlinker.com announces that a ... catalogue: South and Central America ... http://www.reportlinker.com/p0548448/South-and-Central-America-Dental-Devices-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Dental_Equipment South and ... Summary GlobalData,s ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: ... second quarter ending June 30, 2011, to approximately $122 million, ... second quarter of 2010, an anticipated one percent year-over-year increase. ... due to a mathematical error. The forecasted growth is primarily ...
Cached Medicine Technology:Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 2Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 3Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 4Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 5Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 6Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 7Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 8Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 9Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 10Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 11Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 12Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 13PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 2PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 3PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 4
(Date:9/29/2014)... NY (PRWEB) September 30, 2014 ... F.A.A.P., Owner and President of Private Pediatrics of ... the Year. She is recognized for leadership in pediatrics ... largest, most-recognized organization of women in the country, spanning ... Professional Women (NAPW) is a powerfully vibrant networking community ...
(Date:9/29/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... iPage are the most recommended suppliers that provide ... “Our research is based on performance, popularity, feature, ... Justhost and iPage are the most recommended SEO ... have been working in the hosting industry for ...
(Date:9/29/2014)... 2014 Each year over 8 million ... of dizziness and imbalance. Symptoms of vestibular disorders can ... the population range can vary as much as the ... be seeking medical assistance for dizziness and imbalance or ... with post blast or post concussion injuries often have ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer ... D.D. and Velma Davis Family YMCA in Boardman and St. ... to manage their weight by making lifestyle changes with regard ... 5:30 to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg ... at the Mall (next to the rear entrance to Sears) ...
(Date:9/29/2014)... Rodrigo Guerrero, a Harvard-trained epidemiologist and mayor of Cali, ... a new US$100,000 award for turning evidence into health ... Dr. Guerrero,s success in dramatically reducing the toll of ... one of the most violent in the countryhas influenced ... , The Roux Prize is given by the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Top 10 Best SEO Hosting Recommends GreenGeeks, Justhost And iPage To Webmasters Worldwide 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 2Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 3Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 4
... full, study suggests , , MONDAY, June 16 (HealthDay News) -- ... sweeteners may help you feel fuller faster and decrease the ... this may be a new way to help people lose ... can stimulate the sense of taste -- included 2,436 overweight ...
... La.The first patient scans from a custom-built scanner ... (CT) technologies indicate that these scans could significantly ... more targeted treatment options, according to researchers at ... designed to help physicians determine stages of breast ...
... NEW ORLEANS, La.A new study, presented at the ... pre-target the treatment of cancer cellsbringing personalized medicine ... By combining new molecular imaging techniques with targeted ... treatment that can increase the effectiveness of therapies ...
... tomography (PET) and computed tomography (CT) scanning of ... can enable physicians to determine whether the cancer ... to perform surgery, according to researchers at the ... surgeries could be reduced, which would also lower ...
... are developing new technology to create individualised brain maps ... accuracy of brain surgery. , Currently researchers and ... that are based on a small number of individuals, ... differences that can occur between people,s brains. , The ...
... Jersey Hospital, RIDGEWOOD, N.J., June 16 Ridgewood resident,David ... historic charitable contribution to The Valley Hospital in,Ridgewood, NJ. The ... its main campus, is thought to be the largest single ... gift to Valley because I want my giving to do ...
Cached Medicine News:Health News:Flavoring Food May Promote Weight Loss 2Health News:Flavoring Food May Promote Weight Loss 3Health News:New possibilities for breast cancer treatment on the horizon 2Health News:Personalizing medicine: New research shows potential of targeted therapies for cancer 2Health News:PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer 2Health News:Developing unique brain maps to assist surgery and research 2Health News:The Valley Hospital in Ridgewood, NJ, Announces Historic $30 Million Gift 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: